12:00 AM
Jun 19, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Inhaled insulin: Phase II data; Phase III

INHL and partners Pfizer Inc. (PFE; New York, N.Y.) and Aventis S.A. (AVE, Strasbourg, France) said that HbA1c levels (a measure of glucose control) remained stable in...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >